Oct1 Monoclonal Antibody(7G1)

The OCT1 transcription factor was among the first identified members of the POU transcription factor family (summarized by Sturm et al., 1993 [PubMed 8314572]). Members of this family contain the POU domain, a 160-amino acid region necessary for DNA binding to the octameric sequence ATGCAAAT.[supplied by OMIM, Jul 2010],

Introducing the OCT1 Monoclonal Antibody (7G1), a cutting-edge product designed to revolutionize the field of biomedical research. This highly advanced antibody is meticulously engineered to specifically target and bind to the organic cation transporter 1 (OCT1) protein, enabling researchers to gain unprecedented insights into its function and role in various physiological processes.

The OCT1 Monoclonal Antibody (7G1) boasts exceptional specificity and affinity, ensuring accurate and reliable results in a wide range of experimental applications. Its superior performance is attributed to the rigorous development process, which involved extensive optimization and validation to guarantee optimal binding and minimal cross-reactivity.

With its exceptional sensitivity, the OCT1 Monoclonal Antibody (7G1) allows for precise detection and quantification of OCT1 protein expression levels in various biological samples. This invaluable tool empowers researchers to unravel the intricate mechanisms underlying drug transport, metabolism, and disposition, ultimately leading to the development of more effective therapeutic strategies.

Furthermore, the OCT1 Monoclonal Antibody (7G1) exhibits exceptional versatility, making it suitable for use in diverse experimental techniques such as immunohistochemistry, immunofluorescence, and Western blotting. Its robust performance across multiple platforms ensures seamless integration into existing research protocols, facilitating efficient and streamlined investigations.

In addition to its exceptional scientific capabilities, the OCT1 Monoclonal Antibody (7G1) is manufactured to the highest quality standards, ensuring consistency and reproducibility across batches. Each vial is meticulously tested and validated to guarantee optimal performance, providing researchers with the utmost confidence in their experimental results.

In summary, the OCT1 Monoclonal Antibody (7G1) represents a groundbreaking advancement in the field of biomedical research. Its unrivaled specificity, sensitivity, and versatility make it an indispensable tool for elucidating the intricate functions of the OCT1 protein. With its exceptional performance and uncompromising quality, this antibody is poised to revolutionize the understanding and treatment of various diseases, paving the way for novel therapeutic interventions.